Altamira Therapeutics
CYTO
#10318
Rank
ยฃ0.84 M
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
ยฃ0.22
Share price
0.00%
Change (1 day)
-82.18%
Change (1 year)

EPS for Altamira Therapeutics (CYTO)

EPS in 2019 (TTM): -ยฃ235.16

According to Altamira Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ229.43. In 2018 the company made an earnings per share (EPS) of -ยฃ323.12 an increase over its 2017 EPS that were of -ยฃ1,746.

EPS history for Altamira Therapeutics from 2013 to 2019

Annual EPS

Year EPS Change
2019 (TTM)-ยฃ235.16-27.22%
2018-ยฃ323.12-81.5%
2017-ยฃ1,746-36.52%
2016-ยฃ2,751-5.17%
2015-ยฃ2,9017.77%
2014-ยฃ2,6920.33%
2013-ยฃ2,683